MAXCYTE, INC. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Maxcyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Maxcyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.37M, a 6.62% decline year-over-year.
  • Maxcyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $13.5M, a 0% decline year-over-year.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 19% increase from 2022.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.8M, a 47.7% increase from 2021.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.96M, a 222% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14M +$2.23M +19% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $11.8M +$3.79M +47.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $7.96M +$5.49M +222% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $2.47M +$720K +41.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $1.75M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.